MikroScore
Science-backed ingredient evidence
Moderate Evidence Safety: Safe Study dose: 100 mg/day

Vitamin B2 (Riboflavin)

Also known as: Riboflavin, Vitamin B2, Lactoflavin

Summary Moderate Evidence

Vitamin B2 is essential for energy metabolism and antioxidant defence. Most relevant for deficiency correction and potentially for migraine prevention in susceptible individuals.

EU Health Claims: Approved

EU health claims for riboflavin are approved for contribution to normal energy metabolism, nervous system function, red blood cell formation, skin and hair maintenance, vision, and protection against oxidative stress. All relate to normal physiological function.

AI Summary

Quick verdict

Vitamin B2 is essential for energy metabolism and antioxidant defence. Most relevant for deficiency correction and potentially for migraine prevention in susceptible individuals.

What the evidence supports

Riboflavin as an essential nutrient is relatively well-studied. Solid evidence exists for high-dose riboflavin (400 mg/day) in migraine prophylaxis.

What is NOT supported

Long-term safety and rare adverse effects in humans remain insufficiently studied.

EU/EFSA status

Approved. EU health claims for riboflavin are approved for contribution to normal energy metabolism, nervou…

Safety

Safe

This AI summary is generated from the structured data on this page.

What is Vitamin B2?

Vitamin B2, also known as riboflavin, is a water-soluble B vitamin that serves as a precursor to two essential coenzymes: FAD (flavin adenine dinucleotide) and FMN (flavin mononucleotide). These coenzymes are required for dozens of metabolic reactions across the body, making riboflavin genuinely central to cellular function.

Without adequate B2, the electron transport chain—the core machinery of ATP production in mitochondria—cannot function properly. This is not a peripheral biochemical detail; it is fundamental to energy production in every cell.

What is well-established?

Riboflavin as an essential nutrient

B2 deficiency, though rare in industrialised countries, does occur and causes predictable symptoms:

  • Dermatitis (inflamed, cracked skin around the mouth and nose)
  • Glossitis (inflamed tongue)
  • Mouth ulcers and cheilosis (cracks in lips and mouth)
  • Anaemia (due to impaired red blood cell synthesis)
  • Weakness and fatigue

These symptoms are reversible with supplementation. True ariboflavinosis is now rare in developed nations, but deficiency can emerge in:

  • Severe malabsorption (inflammatory bowel disease, coeliac disease)
  • Chronic alcoholism
  • Use of certain medications (antifungals, sulphonamides, tricyclic antidepressants)
  • Genetic mitochondrial disorders requiring higher intake

Migraine prophylaxis

The most credible non-deficiency application for high-dose riboflavin is migraine prevention. A 1998 RCT by Schoenen and colleagues (N=55) found that 400 mg daily reduced migraine attack frequency by approximately 67% versus placebo over a 3-month period. This effect size is meaningful and ranks among the better-supported supplement interventions in migraine research.

The mechanism likely involves improved mitochondrial ATP production—migraine sufferers sometimes show mitochondrial dysfunction on specialised testing—though the mechanism is not fully understood.

Important caveats:

  • Responder rates vary widely; roughly 40–60% of migraine sufferers see meaningful benefit
  • Onset of benefit typically takes 2–4 weeks; a 3-month trial is reasonable before concluding non-response
  • Not all migraine types respond equally (episodic migraine may respond better than chronic daily headache)

Regulatory status

The European Food Safety Authority has approved health claims for riboflavin relating to:

  • Contribution to normal energy metabolism
  • Support for nervous system function
  • Normal red blood cell formation
  • Contribution to immune system function
  • Maintenance of normal vision
  • Maintenance of normal skin and hair
  • Protection against oxidative stress

These are all substantiated claims for normal physiological function. No treatment or disease claims are permitted.

What is NOT well-established?

Enhanced energy in people with normal B2 status

There is no credible evidence that supplementing with extra riboflavin increases energy, alertness, or stamina in people with adequate B2 intake. B2 may be necessary for energy production, but more is not better.

Anti-ageing and longevity effects

Riboflavin appears in various “longevity supplement” lists, typically because it supports mitochondrial function. However, there is no human evidence that supplementation extends lifespan or healthspan in normally-nourished populations. Animal model data exist, but translation to human benefit remains speculative.

Athletic performance

Unlike some B vitamins (e.g., beta-alanine, beetroot nitrate), riboflavin supplementation is not associated with improvements in endurance, strength, or power output in controlled trials.

Cardiovascular or metabolic benefits

Although riboflavin participates in homocysteine metabolism (an emerging cardiovascular risk factor), supplementation has not been shown in rigorous trials to meaningfully lower CVD risk or improve metabolic markers in people with normal B2 status.

Safety and dosing

Toxicity

Riboflavin is exceptionally safe. As a water-soluble vitamin, excess amounts are simply excreted in urine. No upper intake limit (UL) has been established by regulatory authorities due to the extremely low toxicity risk. Clinical trials using doses of 400 mg daily show no adverse effects beyond cosmetic ones.

Visual effects

The only consistent effect of high-dose supplementation is bright yellow discolouration of urine—harmless but striking. This occurs at doses above ~100–150 mg and is simply excess riboflavin being excreted. It is not a warning sign; it is normal excretion of a water-soluble vitamin.

Standard dosing

  • RDA (recommended dietary allowance): 1.1 mg/day (women), 1.3 mg/day (men)
  • Upper intake limit (UL): Not established
  • Migraine trial dose: 400 mg daily, typically divided into 100 mg doses (two or four times daily)
  • Forms: Free riboflavin, riboflavin-5-phosphate (activated form), FADH₂-based precursors

The phosphorylated forms may have slightly improved bioavailability in some disease states, but for healthy individuals, the clinical difference is modest.

Bottom line

Vitamin B2 is a foundational nutrient—not exotic, not a longevity hack, but genuinely important for human health. It is most relevant when:

  1. Deficiency is present or likely (malabsorption, certain medications, strict vegan diet): supplementation is medically indicated.
  2. Migraine is a problem: A 3-month trial of 400 mg daily is a rational, evidence-informed approach with reasonable odds of benefit (~50%) and minimal risk.
  3. General health: Including adequate B2 through diet or a standard multivitamin is sensible; extra supplementation beyond meeting RDA is unlikely to provide noticeable benefit.

Riboflavin is inexpensive, very safe, and integrates easily into supplement stacks. If you are considering it for migraine, the evidence base is solid (Level 2). Realistic expectations: roughly half of users will see a meaningful reduction in attack frequency; onset takes 2–4 weeks.

Key Studies

Effectiveness of high-dose riboflavin in migraine prophylaxis

Schoenen J et al. (1998) n=55

RCT (N=55): 400 mg riboflavin daily reduced migraine attack frequency by ~67% versus placebo over 3 months. One of the best-established high-dose B2 clinical applications, though responder rates vary widely (40–60% in replicated studies).

PubMed PMID 9484373

Riboflavin Deficiency Is Highly Prevalent in Females and Children across High and Low/Middle Income Countries Worldwide

McAnena et al. (2026)

Review: Suboptimal B2 status can occur even in developed countries, particularly in specific populations (malabsorption, strict vegan diets, certain medications), though typically without frank clinical deficiency symptoms.

PubMed PMID 41735095

Products with Vitamin B2 (Riboflavin)

No reviewed products yet — we're working on it.

See all reviewed products →
Editorial notice: For most ingredients described here, no health claims are approved in the EU (Regulation (EC) 1924/2006). Evidence levels are editorial assessments of research quality — not health promises. This content is not a substitute for medical advice and does not constitute a recommendation to treat, alleviate, or prevent any disease.